- Home
- UAA vs APGE Comparison
UAA vs APGE Comparison
Compare UAA & APGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | UAA | APGE |
|---|---|---|
| Founded | 1996 | 2022 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Apparel | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2B | 4.7B |
| IPO Year | N/A | 2023 |
Fundamental Metrics
Financial Performance| Metric | UAA | APGE |
|---|---|---|
| Price | $4.32 | $76.40 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 19 | 8 |
| Target Price | $6.34 | ★ $100.00 |
| AVG Volume (30 Days) | ★ 7.9M | 757.0K |
| Earning Date | 11-06-2025 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $5,049,070,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $1.54 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $4.13 | $26.20 |
| 52 Week High | $10.28 | $78.12 |
Technical Indicators
Market Signals| Indicator | UAA | APGE |
|---|---|---|
| Relative Strength Index (RSI) | 41.72 | 72.83 |
| Support Level | $4.29 | $74.00 |
| Resistance Level | $4.46 | $76.87 |
| Average True Range (ATR) | 0.15 | 3.40 |
| MACD | -0.01 | 0.02 |
| Stochastic Oscillator | 20.00 | 87.77 |
Price Performance
Historical ComparisonAbout UAA Under Armour Inc.
Under Armour develops, markets, and distributes athletic apparel, footwear, and accessories in North America, Asia-Pacific, Europe, and elsewhere. Consumers of its performance-based clothing and shoes include professional and amateur athletes, sponsored college and professional teams, and people with active lifestyles. The company sells merchandise through direct-to-consumer, including e-commerce and more than 400 combined factory house and brand house stores, and wholesale channels. The Baltimore-based company was founded in 1996 and is led by controlling shareholder Kevin Plank.
About APGE Apogee Therapeutics Inc.
Apogee Therapeutics Inc is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology (I&I) indications with high unmet need. Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.